Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.

Salantes DB, Zheng Y, Mampe F, Srivastava T, Beg S, Lai J, Li JZ, Tressler RL, Koup RA, Hoxie J, Abdel-Mohsen M, Sherrill-Mix S, McCormick K, Overton ET, Bushman FD, Learn GH, Siliciano RF, Siliciano JM, Tebas P, Bar KJ.

J Clin Invest. 2018 Jul 2;128(7):3102-3115. doi: 10.1172/JCI120194. Epub 2018 Jun 18.

2.

Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells.

Hansen EC, Ransom M, Hesselberth JR, Hosmane NN, Capoferri AA, Bruner KM, Pollack RA, Zhang H, Drummond MB, Siliciano JM, Siliciano R, Stivers JT.

Elife. 2016 Sep 20;5. pii: e18447. doi: 10.7554/eLife.18447.

3.

Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1.

Rosenbloom DI, Elliott O, Hill AL, Henrich TJ, Siliciano JM, Siliciano RF.

Open Forum Infect Dis. 2015 Aug 26;2(4):ofv123. doi: 10.1093/ofid/ofv123. eCollection 2015 Dec. Review.

4.

The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells.

Siliciano JM, Siliciano RF.

J Infect Dis. 2015 Nov 1;212(9):1345-7. doi: 10.1093/infdis/jiv219. Epub 2015 Apr 15. No abstract available.

PMID:
25877551
5.

Targeting HIV reservoirs with valproic acid.

Siliciano JM, Siliciano RF.

Hopkins HIV Rep. 2005 Sep;17(5):8-9. No abstract available.

PMID:
16419304
6.

Latency in human immunodeficiency virus type 1 infection: no easy answers.

Persaud D, Zhou Y, Siliciano JM, Siliciano RF.

J Virol. 2003 Feb;77(3):1659-65. Review. No abstract available.

Supplemental Content

Loading ...
Support Center